Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹4,648 Cr₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,648 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹4,648 Cr
Mar2025₹4,209 Cr
Mar2024₹3,743 Cr
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2026 ₹4,648 Cr
10.44
Mar2025 ₹4,209 Cr
12.45
Mar2024 ₹3,743 Cr
12.02
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹42,106.3 Cr -1.5% 14.4% 31.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1.5%

14.4%

31.7%

SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses